Stoke Therapeutics - 53 Year Dividend History | STOK
Historical dividend payout and yield for Stoke Therapeutics (STOK) since 1971. The current TTM dividend payout for Stoke Therapeutics (STOK) as of December 20, 2024 is $0.00. The current dividend yield for Stoke Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.639B |
$0.009B |
|
Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
